These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

448 related articles for article (PubMed ID: 23488524)

  • 1. Global consensus statement on menopausal hormone therapy.
    de Villiers TJ; Gass ML; Haines CJ; Hall JE; Lobo RA; Pierroz DD; Rees M
    Climacteric; 2013 Apr; 16(2):203-4. PubMed ID: 23488524
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The 2017 hormone therapy position statement of The North American Menopause Society.
    Menopause; 2018 Nov; 25(11):1362-1387. PubMed ID: 30358733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Menopause and hormone replacement therapy: the 2017 Recommendations of the Italian Menopause Society.
    Gambacciani M; Biglia N; Cagnacci A; Caruso S; Cicinelli E; DE Leo V; DI Carlo C; Farris M; Gambera A; Guaschino S; Lanzone A; Paoletti AM; Russo N; Vicariotto F; Villa P; Volpe A;
    Minerva Ginecol; 2018 Feb; 70(1):27-34. PubMed ID: 28975776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The 2017 hormone therapy position statement of The North American Menopause Society.
    The NAMS 2017 Hormone Therapy Position Statement Advisory Panel
    Menopause; 2017 Jul; 24(7):728-753. PubMed ID: 28650869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of osteoporosis in postmenopausal women: 2010 position statement of The North American Menopause Society.
    Menopause; 2010; 17(1):25-54; quiz 55-6. PubMed ID: 20061894
    [TBL] [Abstract][Full Text] [Related]  

  • 6. South African Menopause Society Council consensus statement on menopausal hormone therapy.
    de Villiers TJ;
    S Afr Med J; 2004 Sep; 94(9):760-2. PubMed ID: 15487841
    [No Abstract]   [Full Text] [Related]  

  • 7. Estrogen and progestogen therapy in postmenopausal women.
    Practice Committee of the American Society for Reproductive Medicine
    Fertil Steril; 2006 Nov; 86(5 Suppl 1):S75-88. PubMed ID: 17055850
    [No Abstract]   [Full Text] [Related]  

  • 8. Revised global consensus statement on menopausal hormone therapy.
    de Villiers TJ; Hall JE; Pinkerton JV; Pérez SC; Rees M; Yang C; Pierroz DD
    Maturitas; 2016 Sep; 91():153-5. PubMed ID: 27389038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hormone replacement therapy and the menopause. Australian Menopause Society.
    MacLennan AH
    Med J Aust; 1991 Jul; 155(1):43-4. PubMed ID: 2067437
    [No Abstract]   [Full Text] [Related]  

  • 10. Updated 2013 International Menopause Society recommendations on menopausal hormone therapy and preventive strategies for midlife health.
    de Villiers TJ; Pines A; Panay N; Gambacciani M; Archer DF; Baber RJ; Davis SR; Gompel AA; Henderson VW; Langer R; Lobo RA; Plu-Bureau G; Sturdee DW;
    Climacteric; 2013 Jun; 16(3):316-37. PubMed ID: 23672656
    [No Abstract]   [Full Text] [Related]  

  • 11. Update: estrogen and estrogen plus progestin therapy in the care of women at and after the menopause.
    Davey DA
    Womens Health (Lond); 2012 Mar; 8(2):169-89. PubMed ID: 22375720
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A decision tree for the use of estrogen replacement therapy or hormone replacement therapy in postmenopausal women: consensus opinion of The North American Menopause Society.
    Menopause; 2000; 7(2):76-86. PubMed ID: 10746889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hormone therapy and breast cancer: the press-release version of WHI study data.
    Pines A
    Climacteric; 2013 Apr; 16(2):222-5. PubMed ID: 23488525
    [No Abstract]   [Full Text] [Related]  

  • 14. Prevention and management of osteoporosis: consensus statements from the Scientific Advisory Board of the Osteoporosis Society of Canada. 3. Effects of ovarian hormone therapy on skeletal and extraskeletal tissues in women.
    Josse RG
    CMAJ; 1996 Oct; 155(7):929-34. PubMed ID: 8837542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The rationale for low-dose hormonal therapy.
    Lobo RA
    Endocrine; 2004 Aug; 24(3):217-21. PubMed ID: 15542888
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estrogen and progestogen use in postmenopausal women: 2010 position statement of The North American Menopause Society.
    North American Menopause Society
    Menopause; 2010 Mar; 17(2):242-55. PubMed ID: 20154637
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Landmark hormone replacement therapy study stopped after finding more harms than benefits.
    Rollins G
    Rep Med Guidel Outcomes Res; 2002 Aug; 13(15):5-7. PubMed ID: 12553323
    [No Abstract]   [Full Text] [Related]  

  • 18. EMAS position statement: Managing the menopause in the context of coronary heart disease.
    Schenck-Gustafsson K; Brincat M; Erel CT; Gambacciani M; Lambrinoudaki I; Moen MH; Tremollieres F; Vujovic S; Rozenberg S; Rees M;
    Maturitas; 2011 Jan; 68(1):94-7. PubMed ID: 21156341
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hormone replacement therapy and breast cancer--any news?].
    Holli K
    Duodecim; 1999; 115(2):101-2. PubMed ID: 11830839
    [No Abstract]   [Full Text] [Related]  

  • 20. A practical guide to prescribing estrogen replacement therapy.
    Corson SL
    Int J Fertil Menopausal Stud; 1995; 40(5):229-47. PubMed ID: 8556028
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.